127.90
-1.38(-1.07%)
Currency In USD
| Previous Close | 129.28 |
| Open | 128.9 |
| Day High | 129.26 |
| Day Low | 127.74 |
| 52-Week High | 219.44 |
| 52-Week Low | 110.04 |
| Volume | 1.04M |
| Average Volume | 1.44M |
| Market Cap | 18.74B |
| PE | 12.64 |
| EPS | 10.12 |
| Moving Average 50 Days | 129.68 |
| Moving Average 200 Days | 142.95 |
| Change | -1.38 |
If you invested $1000 in Biogen Inc. (BIIB) 10 years ago, it would be worth $403.47 as of July 30, 2025 at a share price of $127.9. Whereas If you bought $1000 worth of Biogen Inc. (BIIB) shares 5 years ago, it would be worth $465.33 as of July 30, 2025 at a share price of $127.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
GlobeNewswire Inc.
Jul 25, 2025 11:20 AM GMT
CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorizatio
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
GlobeNewswire Inc.
Jul 21, 2025 11:30 PM GMT
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the development of targeted therapies and biomarkers, a
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
GlobeNewswire Inc.
Jul 21, 2025 11:30 AM GMT
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – today announced it intends to invest an a